188 related articles for article (PubMed ID: 37160910)
1. Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.
Atobatele AG; Tonoli E; Vadakekolathu J; Savoca MP; Barr M; Kataria Y; Rossanese M; Burhan I; McArdle S; Caccamo D; Verderio EAM
Cell Death Dis; 2023 May; 14(5):317. PubMed ID: 37160910
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.
Han AL; Kumar S; Fok JY; Tyagi AK; Mehta K
Eur J Cancer; 2014 Jun; 50(9):1685-96. PubMed ID: 24656569
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
Rajabi H; Joshi MD; Jin C; Ahmad R; Kufe D
Prostate; 2011 Sep; 71(12):1299-308. PubMed ID: 21308711
[TBL] [Abstract][Full Text] [Related]
4. MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.
Rajabi H; Ahmad R; Jin C; Joshi MD; Guha M; Alam M; Kharbanda S; Kufe D
Prostate; 2012 Nov; 72(15):1659-68. PubMed ID: 22473899
[TBL] [Abstract][Full Text] [Related]
5. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
7. Androgen-dependent regulation of human MUC1 mucin expression.
Mitchell S; Abel P; Madaan S; Jeffs J; Chaudhary K; Stamp G; Lalani el-N
Neoplasia; 2002; 4(1):9-18. PubMed ID: 11922395
[TBL] [Abstract][Full Text] [Related]
8. Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.
Wang H; Chen J; Jandu S; Melucci S; Savage W; Nandakumar K; Kang SK; Barreto-Ortiz S; Poe A; Rastogi S; Bauer M; Steppan J; Santhanam L
Cell Death Discov; 2021 Jul; 7(1):197. PubMed ID: 34326316
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
10. Amplification of MUC1 in prostate cancer metastasis and CRPC development.
Wong N; Major P; Kapoor A; Wei F; Yan J; Aziz T; Zheng M; Jayasekera D; Cutz JC; Chow MJ; Tang D
Oncotarget; 2016 Dec; 7(50):83115-83133. PubMed ID: 27825118
[TBL] [Abstract][Full Text] [Related]
11. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
12. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Ai L; Kim WJ; Demircan B; Dyer LM; Bray KJ; Skehan RR; Massoll NA; Brown KD
Carcinogenesis; 2008 Mar; 29(3):510-8. PubMed ID: 18174247
[TBL] [Abstract][Full Text] [Related]
13. Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer.
Phatak VM; Croft SM; Rameshaiah Setty SG; Scarpellini A; Hughes DC; Rees R; McArdle S; Verderio EA
Amino Acids; 2013 Jan; 44(1):33-44. PubMed ID: 22089883
[TBL] [Abstract][Full Text] [Related]
14. The transglutaminase 2 gene is aberrantly hypermethylated in glioma.
Dyer LM; Schooler KP; Ai L; Klop C; Qiu J; Robertson KD; Brown KD
J Neurooncol; 2011 Feb; 101(3):429-40. PubMed ID: 20596752
[TBL] [Abstract][Full Text] [Related]
15. Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition-Evidence for the Role for TG1 in Osteoclast Formation.
Ebrahimi Samani S; Kaartinen MT
Cells; 2023 Aug; 12(17):. PubMed ID: 37681871
[TBL] [Abstract][Full Text] [Related]
16. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel androgen receptor target genes in prostate cancer.
Jariwala U; Prescott J; Jia L; Barski A; Pregizer S; Cogan JP; Arasheben A; Tilley WD; Scher HI; Gerald WL; Buchanan G; Coetzee GA; Frenkel B
Mol Cancer; 2007 Jun; 6():39. PubMed ID: 17553165
[TBL] [Abstract][Full Text] [Related]
19. MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue.
Schut IC; Waterfall PM; Ross M; O'Sullivan C; Miller WR; Habib FK; Bayne CW
BJU Int; 2003 Feb; 91(3):278-83. PubMed ID: 12581019
[TBL] [Abstract][Full Text] [Related]
20. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
